贊助商

 


Corporate Sponsors

    Curia    OmniAb  SpiroChem  STEMCELL-Technologies

Corporate Support Sponsors

Ardigen_new Aurigene_Pharmaceutical_Services_NEW  Biointron_newbiosensing-instrument-logoBPS Bioscience NEWCovaLX      GENOVAC  Medicilon  OpenEye_TaglinePromega SaiSyngene_tagline  Wuxi-Apptecx-chem_Pharmaceuticals  

Choose your language
Chinese
Japanese
Korean
English

Conference at a Glance
View Event Testimonial Highlights
Submit a Poster
View All Sponsors

會議議程

9月22日

Covalent Chemistries & Induced Proximity
共價化學和誘導接近 Strategies for Targeting Kinases
靶向激酶的策略 Emerging Immune Modulation Strategies
新興的免疫調節策略 3D Models & NAMs in Drug Development
藥物開發中的 3D 模型和 NAMs Synthetic Biology for Drug Discovery & Development
用於藥物發現和開發的合成生物學

9月23日 - 24日

Degraders & Molecular Glues – Part 1
降解劑和分子膠 - PART1 Emerging Drug Targets: Identification & Validation
新興藥物靶點：鑒定與驗證 Small Molecules for Cancer Targets
用於癌症靶點的小分子 Antibodies Against Membrane Protein Targets
針對膜蛋白靶標的抗體 RNA & DNA Targeting Small Molecule Drugs
RNA & DNA 靶向小分子藥物 AI/ML-Enabled Drug Discovery - Part 1
AI/ML 支援的藥物發現 - PART1 Targeting MASH & Obesity NEW
針對MASH和肥胖

9月24日 - 25日

Degraders & Molecular Glues – Part 2
降解劑和分子膠 - PART2 Lead Generation Strategies
潛在客戶開發策略 Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
多特異性抗體、抗體偶聯藥物 (ADC) 和生物製劑中的新興癌症標靶 GPCR-Based Drug Discovery
基於GPCR的藥物發現 Targeting Transcription Factors & Regulators
靶向轉錄因子和調控因子 AI/ML-Enabled Drug Discovery - Part 2
AI/ML 支援的藥物發現 - PART2 TS: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics
TS：標靶藥物暴露：ADME 和藥物動力學的作用